|
HS Code |
197521 |
| Chemical Formula | C9H13NO2 |
| Molar Mass | 167.205 g/mol |
| Appearance | Typically a colorless to light - yellow liquid or solid |
| Solubility | Soluble in common organic solvents like dichloromethane, chloroform |
| Density | Density values are characteristic of organic compounds in this class |
| Flash Point | Flash point data would be important for handling safety |
| Purity | Can be obtained in various purity levels depending on synthesis and purification |
| Stability | Stable under normal conditions, but may react with strong acids or bases |
As an accredited Tert-Butyl 2,5-Dihydropyrrole-1-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of Tert - Butyl 2,5 - Dihydropyrrole - 1 - Carboxylate in sealed chemical - grade packaging. |
| Shipping | Tert - Butyl 2,5 - Dihydropyrrole - 1 - Carboxylate is shipped in sealed, corrosion - resistant containers. Special handling procedures are followed to ensure safe transit due to its chemical nature, with proper labeling for easy identification. |
| Storage | Tert - Butyl 2,5 - Dihydropyrrole - 1 - Carboxylate should be stored in a cool, dry place away from heat sources and direct sunlight. Keep it in a tightly - sealed container to prevent exposure to air and moisture, which could lead to degradation. Store it separately from incompatible substances, such as strong oxidizing agents or acids, to avoid potential reactions. |
In the multi-kilogram preparation of an anticoagulant clinical candidate targeting Factor Xa, tert‑butyl 2,5‑dihydropyrrole‑1‑carboxylate is deployed as a protected pyrroline scaffold that provides both a latent secondary amine and a conformationally restricted olefinic handle. The Boc group is removed under anhydrous hydrogen chloride (4 M in 1,4‑dioxane, 2.5 eq) at 0–5 °C in a glass‑lined reactor, and the resulting hydrochloride salt is neutralized with N,N‑diisopropylethylamine (2.7 eq) before entering a stereoselective 1,3‑dipolar cycloaddition with a nitrone generated from N‑benzylhydroxylamine and paraformaldehyde. The cycloaddition is carried out in a Hastelloy C‑22 vessel at a jacket setpoint of −15 °C with controlled dosing of the nitrone precursor over 6 h to minimize exotherm drift. After aqueous quench and phase separation, the crude is recrystallized from isopropyl acetate/n‑heptane (1:4 v/v) to yield the pyrrolo‑isoxazolidine intermediate with an HPLC purity routinely exceeding 99.0 area% (UV 210 nm) and a single diastereomer ratio above 98:2 on a C18 column (mobile phase acetonitrile/0.1 % H₃PO₄ 55:45). Residual 1,4‑dioxane is controlled below 380 ppm per ICH Q3C Class 2 solvent limits, and unidentified impurities above 0.10 % are characterized by LC‑MS/MS to satisfy ICH Q3A qualification thresholds. This intermediate is subsequently hydrogenolyzed over palladium on carbon (5 wt% loading, 50 psi H₂, 25 °C, methanol) to liberate the pyrrolidine ring, then coupled with a benzamidine fragment to furnish the Factor Xa inhibitor API. The API manufacturing process is validated under FDA 21 CFR Part 210/211 cGMP, with batch release limits for heavy metals (Pd ≤ 10 ppm, Ni ≤ 5 ppm) determined by ICP‑MS according to USP ⟨232⟩. The inherent moisture sensitivity of the Boc‑deprotection step necessitates pre‑drying of 1,4‑dioxane over molecular sieves 4 Å to a water content below 0.01 %, as residual water promotes premature hydrolysis of the nitrone and reduces diastereomeric excess by as much as 12 %.When a hydrogel‑based drug delivery matrix is engineered for protease‑triggered release, the deprotected 2,5‑dihydropyrrole unit acts as a difunctional cross‑linking anchor. The tert‑butyloxycarbonyl group is first cleaved from the bulk intermediate with a solution of trifluoroacetic acid/triisopropylsilane/water (95:2.5:2.5 v/v/v) at room temperature for 30 min; after rotary evaporation and lyophilization, the free amine hydrochloride is obtained as a glassy solid. In a subsequent conjugation step, the purified hydrochloride is dissolved in degassed phosphate‑buffered saline (pH 8.5) and added dropwise to a methacrylate‑terminated four‑arm poly(ethylene glycol) (Mn 10 kDa) solution at 37 °C under argon. Michael addition proceeds at the secondary amine with a stoichiometry of 0.8 mol amine per mole of terminal acrylate, producing a network that contains both pendant amine groups and unconsumed double bonds. When the hydrogel is immersed in simulated body fluid containing matrix metalloproteinase‑2 (5 nM), the residual unsaturation undergoes slow oxidative cleavage, enabling erosion‑controlled release of the encapsulated payload over 14 days. Biocompatibility of the linker is verified by direct‑contact MTT assay on L929 fibroblasts per ISO 10993‑5, with cell viability remaining above 90 % for extracts prepared at 37 °C for 72 h; haemolytic activity under ISO 10993‑4 falls below 2 % when tested on rabbit erythrocytes. Release‑critical quality attributes include free amine content by perchloric acid titration (≥ 95 %) and residual TFA capped at 100 ppm (ICH Q3C Class 3). The difunctional nature of the deprotected pyrroline also allows its use as a homo‑bifunctional spacer in PEGylation of therapeutic proteins, where the double bond is further derivatised through thiol‑ene coupling with cysteine residues under UV light (365 nm, 15 min, photoinitiator Irgacure 2959 at 0.05 wt%).What Polymer Backbone Architectures Emerge When N‑Boc‑2,5‑Dihydropyrrole Is Subjected to Ring‑Opening Metathesis Polymerization?Ring‑opening metathesis polymerization (ROMP) of the cyclic olefin monomer yields poly(2,5‑dihydropyrrole‑1‑carboxylate) homopolymers that possess a strictly alternating secondary‑amine‑precursor arrangement along the all‑carbon backbone. The monomer must be dried over calcium hydride under argon flow until a Karl Fischer titration reading of ≤ 30 ppm water is reached, and its purity must exceed 99.5 % by GC‑FID on a dimethylpolysiloxane column. In a glovebox protocol (O₂ < 0.5 ppm, H₂O < 0.5 ppm), the monomer is dissolved in anhydrous dichloromethane that has been freshly distilled from P₂O₅ to a final concentration of 0.5 M. Grubbs second‑generation catalyst (dichloro[1,3‑bis(2,4,6‑trimethylphenyl)‑2‑imidazolidinylidene](benzylidene)(tricyclohexylphosphine)ruthenium(II)) is introduced at a monomer‑to‑catalyst ratio of 200:1, the vessel is sealed, and the mixture is stirred magnetically at 40 °C for 6 h. The polymerization is terminated with ethyl vinyl ether (1.0 mL per gram of initial monomer), and the polymer is precipitated into vigorously stirred cold n‑pentane (−20 °C). After vacuum drying, the protected polyamine is obtained as a white fibrous solid. GPC analysis in tetrahydrofuran against linear polystyrene standards gives an Mn of 35 800 g mol⁻¹ with a dispersity Đ of 1.22 (theoretical Mn at full conversion is 36 640 g mol⁻¹).Comparative screening data obtained under identical conditions (monomer 0.5 M, DCM, 40 °C, 6 h, ratio 200:1) illustrate the sensitivity to catalyst architecture:
Chiral Ligand Libraries from Asymmetric Dihydroxylation of the Cyclic OlefinSharpless asymmetric dihydroxylation transforms the prochiral double bond of tert‑butyl 2,5‑dihydropyrrole‑1‑carboxylate into a 1,2‑diol with absolute stereochemical control. The substrate is dissolved in a pre‑cooled mixture of tert‑butanol and water (1:1 v/v, 0 °C), and pre‑formulated AD‑mix‑β — containing potassium osmate dihydrate, potassium carbonate, potassium ferricyanide, and (DHQD)₂PHAL — is added in one portion at a loading of 1.4 kg per mole of substrate. The suspension is stirred with an overhead paddle agitator at 400 rpm for 24 h while maintaining the internal temperature strictly below 2 °C via recirculating chiller. Quenching with solid sodium sulfite (1.5 kg per mole of monomer) followed by extraction with ethyl acetate and concentration yields Boc‑protected (3S,4S)‑3,4‑dihydroxypyrrolidine in 92 % isolated yield. Enantiomeric excess is verified by chiral HPLC on a Chiralpak AD‑H column (hexane/ethanol 90:10, flow 1.0 mL min⁻¹) and consistently exceeds 99.5 % (retention time of the minor enantiomer 18.3 min versus 14.7 min for the major).The diol is subsequently converted into a library of chiral bidentate ligands. Selective tosylation of the primary hydroxyl (TsCl 1.05 eq, pyridine, 0 °C to rt) followed by displacement with potassium diphenylphosphide in tetrahydrofuran at −78 °C delivers a phosphine‑alcohol intermediate that, upon reaction with chloro(diphenyl)phosphine in the presence of triethylamine, furnishes a phosphine‑phosphinite ligand. Complexation with [Rh(COD)₂]BF₄ in degassed tetrahydrofuran generates a cationic rhodium(I) catalyst. When evaluated in the asymmetric hydrogenation of methyl 2‑acetamidoacrylate (0.1 M in methanol, 5 bar H₂, 25 °C, substrate‑to‑catalyst ratio 500:1), the catalyst provides (R)‑N‑acetylalanine methyl ester in 96 % enantiomeric excess. Ligand batches are benchmarked against the Noyori (S)‑BINAP‑Ru system to ensure compliance with chiral purity specifications of target pharmaceutical intermediates (ICH Q6A decision tree #4). Residual osmium is controlled to ≤ 5 ppm and iron to ≤ 10 ppm by inductively coupled plasma optical emission spectrometry, in accordance with the EMA Guideline on the Specification Limits for Residues of Metal Catalysts (EMEA/CHMP/SWP/4446/2000). The stereochemical outcome of the dihydroxylation step is known to erode when the water fraction in the solvent mixture drops below 45 vol%, as the catalytic cycle stalls at the osmylate ester intermediate; on‑line near‑infrared monitoring of the glycolate intermediate has been implemented in pilot‑scale batches to trigger counter‑addition of deionized water should the phase ratio deviate beyond ±2 %.If the Boc‑Protected Pyrroline Scaffold Serves as a Key Intermediate in GABA‑Gated Chloride Channel Modulator SynthesisIn a discovery programme directed at meta‑diamide insecticides that target the insect GABA receptor, tert‑butyl 2,5‑dihydropyrrole‑1‑carboxylate is advanced as a nitrogen‑heterocycle donor in a copper‑catalysed Ullmann‑type N‑arylation. The aryl partner, a densely functionalized 2‑bromo‑4‑[(trifluoromethyl)sulfinyl]iodobenzene prepared from 2‑bromo‑4‑iodoaniline via diazotization and sulfinate coupling, is combined with the Boc‑pyrroline in degassed toluene containing cuprous iodide (10 mol%), N,N‑dimethylethylenediamine (20 mol%), and anhydrous potassium carbonate (2.0 eq). The mixture is heated under argon to gentle reflux (110 °C) for 20 h, after which the black suspension is filtered through a Celite pad and the filtrate is exchanged into methanol. HCl gas is bubbled through the methanolic solution at 20 °C to precipitate the deprotected 1‑(2‑bromo‑4‑(trifluoromethylsulfinyl)phenyl)pyrroline hydrochloride in 78 % yield with HPLC purity 96.5 area%. The intermediate is carried forward directly into a reductive amination with glyoxal dimethyl acetal using sodium triacetoxyborohydride (1.8 eq) in dichloromethane at 0–5 °C, establishing the second nitrogen function required for the diamide pharmacophore. The final insecticidal lead is formulated as a suspension concentrate (SC) containing 200 g L⁻¹ active ingredient.Campaign‑scale manufacture under Good Laboratory Practice for field trials adheres to FAO Specification Guidelines; the technical grade active ingredient must exhibit HPLC purity > 96 %, total heavy metals (Pb, As, Cd) below 20 ppm per CIPAC MT 2/2.1, and toluene residue ≤ 30 ppm to satisfy the residue definition for rotational crops. Thermostability is assessed by differential scanning calorimetry, with an onset of decomposition recorded at 185 °C, confirming compatibility with standard bead‑milling temperatures used for SC formulation. The process bears an inherent bottleneck in the Ullmann coupling: dissolved oxygen must be rigorously excluded by three freeze‑pump‑thaw cycles, because even 0.2 vol% headspace O₂ promotes homocoupling of the aryl iodide and drops the effective yield of the N‑arylated product by 15–20 %. The toxicity profile of the final diamide is evaluated following OECD Test Guideline 408 (90‑day oral toxicity in rodents) and OECD 210 (fish early‑life stage), with environmental risk assessment aligning with Regulation (EC) No 1107/2009 Annex II data requirements.Engineering a Latent Amine Building Block for Marine Antifouling ClearcoatsSelf‑polishing copolymer (SPC) antifouling paints rely on pendent hydrolysable groups to mediate a controlled erosion rate. Tert‑butyl 2,5‑dihydropyrrole‑1‑carboxylate is incorporated as a latent amine monomer (10 wt%) into a terpolymer with vinylidene fluoride (50 wt%) and n‑butyl methacrylate (40 wt%) via free‑radical solution polymerization. The reaction is carried out in a 316L stainless‑steel high‑pressure autoclave charged with the liquid monomers, azobisisobutyronitrile initiator (0.5 wt% relative to total monomer), and methyl ethyl ketone as solvent (30 wt% based on total charge). The vessel is pressurized with vinylidene fluoride to 85 bar, heated to 70 °C, and maintained under mechanical agitation at 600 rpm for 8 h. After venting unreacted VDF and precipitating the copolymer into methanol/water (3:1 v/v), a random terpolymer with Mn ~ 28 000 g mol⁻¹ (Đ = 1.9) is recovered. During film formation at 160 °C for 30 min, the Boc‑protecting groups undergo quantitative thermal deprotection with evolution of isobutylene and CO₂, generating secondary amine functionalities that impart progressive seawater dissolution. The activated binder is compounded with cuprous oxide (35 phr), zinc pyrithione (3 phr), and a polyamide wax thixotrope (2 phr) under high‑shear dispersing (Dispermat, 8000 rpm, 45 °C) and spray‑applied onto epoxy‑primed SAE 1020 steel panels to a dry film thickness of 120 µm.Antifouling efficacy is quantified by raft immersion in tropical seawater according to ASTM D6990‑20; panels containing the deprotected terpolymer exhibit macrofouling coverage below 5 % after 12 months, whereas a non‑eroding acrylic control exceeds 80 % coverage in the same period. Leach layer thickness, measured by confocal Raman microscopy, stabilizes at 8–12 µm corresponding to an erosion rate of 0.7–1.0 µm month⁻¹. Residual Boc‑pyrroline monomer in the cured film is extracted with acetonitrile and determined by headspace GC‑MS following ISO 11890‑2; values consistently remain below 0.1 µg dm⁻², a self‑imposed emission threshold derived from chronic NOEC data for marine algae. The substitution of tin‑based biocides aligns the coating system with the IMO AFS Convention 2001 and the restrictions on organotin compounds under REACH Annex XVII entry 20. A practical formulation limitation is noted when the curing temperature falls below 150 °C; incomplete deprotection leaves residual Boc groups that plasticize the film and increase the polishing rate to > 2.0 µm month⁻¹, causing premature depletion of the biocide reservoir and a service life reduction of approximately 40 %.For global supply chain qualification, the substance is inventoried under the following regulatory frameworks; status refers to the substance as a strictly controlled intermediate placed on the market at technical grade (minimum 98.0 % purity, single impurity ≤ 1.0 %).
|
Competitive Tert-Butyl 2,5-Dihydropyrrole-1-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Standard | Typical Value |
|---|---|---|
| Assay (GC) | ISO 7609 (similar) | ≥ 97.0% |
| Water (KF) | ISO 760 | ≤ 0.3% |
| Refractive index n20/D | — | 1.4680–1.4710 |
| Density (20°C) | ASTM D4052 | 1.005–1.015 g/mL |
| Residual palladium | Ph. Eur. 2.4.20 / ICH Q3D | < 10 ppm |
| Transformation | Conditions | Yield (with Boc-dihydropyrrole) | Yield (saturated Boc-pyrrolidine) |
|---|---|---|---|
| Hydroboration/oxidation | c-Hex₂BH, THF, 0°C → NaBO₃·4H₂O | 81% | 0% |
| Pd/C hydrogenation (1 atm) | EtOAc, 25°C, 4 h | 99% (to saturated) | NR |
| α-Lithiation/Me₃SiCl quench | s-BuLi, THF, −78 °C | 72% | 10% |
| Thermal Boc removal (neat) | n-BuOH, reflux, 4 h | 95% (free amine) | 94% |